Form 4: EVLV Officer Sells Shares After Option Exercise
Insider Transaction Report
Anil Chitkara, Founder & Chief Growth Officer of Evolv Technologies Holdings, Inc., exercised stock options and subsequently sold 360,000 Class A Common Stock shares for approximately $2.95 million.
Summary
- Anil Chitkara, Founder & Chief Growth Officer of Evolv Technologies Holdings, Inc. (EVLV), reported transactions involving Class A Common Stock.
- On October 24, 2025, Mr. Chitkara acquired 240,000 shares of Class A Common Stock through the exercise of stock options: 70,581 shares at $0.24, 120,000 shares at $0.24, and 49,419 shares at $0.42.
- Concurrently on October 24, 2025, Mr. Chitkara disposed of 240,000 shares of Class A Common Stock through sales at a weighted average price of $8.2 per share, with prices ranging from $8.03 to $8.34.
- On October 27, 2025, Mr. Chitkara acquired an additional 120,000 shares of Class A Common Stock through option exercises: 85,173 shares at $0.24 and 34,827 shares at $0.42.
- Also on October 27, 2025, Mr. Chitkara disposed of 120,000 shares of Class A Common Stock through sales at a weighted average price of $8.2 per share, with prices ranging from $8.13 to $8.30.
- All reported transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
- Following these transactions, Mr. Chitkara directly beneficially owns 1,275,100 shares of Class A Common Stock.
- Remaining derivative securities include 783,324 stock options with an exercise price of $0.24 and an expiration date of September 13, 2027, and 576,968 stock options with an exercise price of $0.42 and an expiration date of January 10, 2031.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive for the insider due to significant profit realization from option exercises and sales. For the company and its shareholders, the sentiment is neutral to slightly cautious, as insider selling can sometimes be viewed negatively, though mitigated by the pre-planned nature of the transactions under a 10b5-1 plan.
Positives
- The executive realized a significant profit by exercising stock options at very low prices ($0.24 and $0.42) and selling the shares at a substantially higher market price (average $8.2).
- The transactions were conducted under a Rule 10b5-1 plan, indicating pre-planned sales not based on immediate, non-public information.
Negatives
- The sale of a significant number of shares by a key executive, even under a 10b5-1 plan, could be perceived negatively by some investors, potentially signaling a lack of confidence or a desire to diversify holdings.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing reports an individual insider transaction and does not provide information directly related to broader industry trends or competitive landscape.
Related Party Transactions
- The reported transactions are related party dealings as they involve an officer of Evolv Technologies Holdings, Inc. exercising stock options granted by the company and selling company shares.
Stakeholder Impact
- Shareholders: May view the insider selling with caution, but the Rule 10b5-1 plan suggests the sales are for personal financial planning rather than a reaction to new negative company information.
- Employees: Those with stock options may see this as a positive example of the potential for significant returns from vested equity.
Key Dates
| Date | Description |
|---|---|
| 01/31/2018 | Date when 25% of certain stock options (exercise price $0.24) vested and became exercisable, with the remainder vesting in 36 equal monthly installments thereafter. |
| 01/01/2022 | Date when 25% of certain stock options (exercise price $0.42) vested and became exercisable, with the remainder vesting in 36 equal monthly installments thereafter. |
| 09/13/2027 | Expiration date for stock options with an exercise price of $0.24. |
| 10/24/2025 | Date of earliest reported transactions, including option exercises and subsequent sales of 240,000 shares. |
| 10/27/2025 | Date of additional reported transactions, including option exercises and subsequent sales of 120,000 shares. |
| 01/10/2031 | Expiration date for stock options with an exercise price of $0.42. |
Recommendation
holdThe filing details pre-planned insider sales by a key executive under a Rule 10b5-1 plan. While the sale of a significant number of shares might raise questions, the pre-arranged nature suggests it's for personal financial planning rather than a reaction to new company-specific negative news. The executive realized substantial gains from exercising options at very low prices and selling at current market rates. This transaction alone does not provide sufficient new information to alter a fundamental investment thesis, thus a 'hold' recommendation is appropriate, pending further company developments or broader market analysis.
Keywords
Evolv Technologies Holdings, EVLV, Anil Chitkara, Insider Trading, Form 4, Stock Options, Share Sale, Officer Transaction, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.